Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Colorectal Neoplasms 3 Brain Neoplasms 3 Rectal Neoplasms 2 Pain, Postoperative 2 Neurotoxicity Syndromes 2 Neoplasms 2 Mesothelioma 2 Colonic Neoplasms 2 Agnosia 2 Urinary Bladder Neoplasms 1 Upper Abdominal Cancer Surgery 1 Thyroid Neoplasms 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Seizures 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Primary Immunodeficiency Diseases 1 Pain 1 Paclitaxel-induced Neuropathy 1 Myoma 1 Leukemia, Myeloid, Acute 1 Infections 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Colorectal Cancer Screening 1 Anesthesia 1

Interventions

Gemcitabine 157 Cisplatin 117 pembrolizumab 81 Cystectomy 46 Nivolumab 42 Carboplatin 42 Paclitaxel 41 Mitomycin 41 Docetaxel 39 atezolizumab 33 Magnetic Resonance Spectroscopy 33 Radiotherapy 31 durvalumab 30 avelumab 26 BCG Vaccine 26 Specimen Handling 25 Cystoscopy 24 enfortumab vedotin 23 Doxorubicin 23 Fluorouracil 20 Methotrexate 17 Vinblastine 16 Standard of Care 15 Ipilimumab 14 Filgrastim 14 5-aminolevulinic acid hexyl ester 14 Transurethral Resection of Bladder 13 Surgical Procedures, Operative 13 Sunitinib 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Magnesium Sulfate × Clear all

NCT07445451 2026-03-03

TURBT

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Phase NA Completed

Urinary Bladder Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡